ALL-026: Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II Study
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 21, S262-S263
- https://doi.org/10.1016/s2152-2650(21)01641-4